Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The queries for the articles about mechanism of GLP-1RAs in liver disease and the clinical experiments: ((GLP-1RAs[Title/Abstract]) OR (GLP-1R agonists[Title/Abstract]) OR (GLP-1 receptor agonists[Title/Abstract]) OR (GLP-1 receptor[Title/Abstract])) AND ((liver[Title/Abstract]) OR (hepatic[Title/Abstract]) OR (HCC[Title/Abstract]) OR (fibrosis[Title/Abstract]) OR (cirrhosis[Title/Abstract]) OR (NAFLD[Title/Abstract]) OR (MASLD[Title/Abstract])) AND ((inflammation[Title/Abstract]) OR (immun*[Title/Abstract]) OR (T cell[Title/Abstract]) OR (B cell[Title/Abstract]) OR (NK cell[Title/Abstract]) OR (macrophage[Title/Abstract]))
Among adults, the rate of severe obesity increased from 5% to 10%
Extended-release medications especially mood-stabilizing medications require extra time
In the SURPASS trial series for type 2 diabetes, tirzepatide achieved hemoglobin A1C reductions of 1.92.6% depending on dose, with many patients reaching non-diabetic glucose levels
In a 2013 study, patients with vitiligo saw pigment return to their skin and eyelashes after exposing their skin with pseudocatalase to sunlight
US$ 28.59
US$ 29.13
US$ 22.83
US$ 22.66
US$ 28.47
US$ 24.13
US$ 28.66
US$ 23.63
US$ 28.27
US$ 22.93
US$ 22.89
